Stock listing

NASDAQ:LVTX LAVA Therapeutics NV Stock

Follow LAVA Therapeutics NV into a list and get an email when it puts out news.

Last close · NASDAQ:LVTX

$1.74 USD

Close on Nov 20, 2025 · No longer trades

Mar 25, 2021 to last close -87.8% · weekly closes, Mar 25, 2021 – Nov 20, 2025
Lowest – highest close
$0.906 – $16.00 USDSince Mar 25, 2021 · lowest Feb 11, 2025 · highest Apr 13, 2021

Delisted NASDAQ:LVTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:LVTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

LAVA Therapeutics NV on 6ix

Decks
8 decks · latest Jun 6, 2024

Decks

DeckKindSlidesDate
Investor Presentation (June 2024)Investor deck28 slidesJun 6, 2024
Investor Presentation (August 2023)Investor deck43 slidesAug 15, 2023
Investor Presentation (April 2023)Investor deck45 slidesApr 24, 2023
Investor Presentation (February 2023)Investor deck46 slidesFeb 16, 2023
Investor Presentation (January 2023)Investor deck40 slidesJan 9, 2023
Investor Presentation (September 2022)Investor deck35 slidesSep 30, 2022
Investor Presentation (January 2022)Investor deck40 slidesJan 7, 2022
Investor Presentation (October 2021)Investor deck41 slidesOct 13, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Karen J. Wilson
Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Serina Therapeutics, Inc. (Director · Since at least Jan 14, 2025); Elicio Therapeutics, Inc. (Director · Since at least Feb 4, 2021); Vaxart, Inc. (Director · Aug 25, 2020 – Jun 16, 2021 · Past); Jazz Pharmaceuticals plc (SVP, Finance & PAO · Mar 9, 2011 – Mar 5, 2019 · Past)
Director · Since at least Jan 1, 2025
James Noble
Other companies: GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2022 · Past)
Director · Since at least Jan 1, 2025
Stephen A Hurly
Other companies: Sesen Bio Inc (President and CEO, Director · Jun 12, 2018 – Jun 12, 2018 · Past); Eleven Biotherapeutics Inc (President and CEO, Director · Sep 20, 2016 – Apr 9, 2018 · Past)
Chief Executive Officer, Director · Since at least Jan 1, 2025
Peter A Kiener
Other companies: Cue Biopharma, Inc. (Director · Since at least Jan 2, 2026)
Director · Since at least Nov 13, 2025

Open People

Log in to ask 6ix AI your own questions about LAVA Therapeutics NV.